Research Article| Volume 90, ISSUE 1, P93-95, May 2000

Poor clinical outcome in early stage cervical cancer with human papillomavirus-18 positive lymph nodes


      Epidemiologic and molecular studies have proven that human papillomavirus (HPV) plays an important role in the development of cervical cancer. However, the role of the virus in the progression of the disease, i.e. in the development of lymph node metastasis and in the adverse clinical outcome is poorly understood. We have been using the polymerase chain reaction (PCR) to study the presence and typing of human papillomavirus DNA since 1980 in cervical cancers and pelvic lymph nodes from the same patients. Out of the series of 47 cervical cancer patients we focused on four women (age: 41, 33, 35 and 56 years) in this article. The follow-up of these patients revealed early recurrences of the disease (7, 7, 17, 22 months) with very short survival (9, 10, 21, 24 months). Although we detected HPV-18 positivity both in the cervical tumors and in the regional lymph nodes too in all four cases, lymph nodes were negative by routine hystology in case of the three young patients (21, 33, 35 years of age). Our observations suggest that HPV type 18 positive cervical cancer patients, despite negative histological findings in the lymph nodes should be consider as a subpopulation for poor outcome especially in the young age group (p=0,022, Fisher’s exact test).


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • zur Hausen H.
        Human papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers.
        Virology. 1991; 184: 9-13
        • Schiffman M.H.
        • Bauer H.M.
        • Hoover R.N.
        • Glass A.G.
        • Cadell D.M.
        • Rush R.B.
        • et al.
        Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.
        J Nat Cancer Inst. 1993; 85: 958-964
        • Kónya J.
        • Veress G.Y.
        • Hernádi Z.
        • Soós G.Y.
        • Czeglédy J.
        • Gergely L.
        Correlation of Human papillomavirus 16 and 18 with prognostic factors in invasive cervical neoplasias.
        J Med Virol. 1995; 46: 1-6
        • Saiki R.K.
        • Scharf S.
        • Falloona F.
        • Mullis K.B.
        • Horn G.T.
        • Erlich H.A.
        • et al.
        Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.
        Science. 1985; 230: 1350-1354
        • Yoshikawa H.
        • Kawana T.
        • Kitagawa K.
        • Mizuno M.
        • Yoshikura H.
        • Iwamoto A.
        Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers.
        Japanese J Cancer Research. 1991; 82: 524-531
        • Czeglédy J.
        • Gergely L.
        • Hernádi Z.
        • Póka R.
        Detection of human papillomavirus deoxyribonucleic acid in the female genital tract.
        Med Microbiol Immunol. 1989; 178: 309-314
        • Czeglédy J.
        • Evander M.
        • Hernádi Z.
        • Gergely L.
        • Wadell G.
        Human papillomavirus type 18 E6 mRNA in primary tumors and pelvic lymph nodes of Hungarian patients with squamous cervical cancer.
        Int J Cancer. 1994; 56: 182-186
        • Kristensen G.B.
        • Karlsen F.
        • Jenkins A.
        • Kaern J.
        • Abeler V.M.
        • Trope C.G.
        Human papilloma virus has no prognostic significance in cervical carcinoma.
        Eur J Cancer. 1996; 32: 1349-1353